M&T Bank
RYTM icon

M&T Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

M&T Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$302K Buy
3,173
+995
+46% +$106K ﹤0.01% 1448
2026
Q2 		$242K Buy
+2,178
New +$197K ﹤0.01% 1565
2026
Q1 		– Sell
-2,101
Closed -$225K – 1793
2025
Q4 		$225K Buy
+2,101
New +$223K ﹤0.01% 1516

Other funds holding RYTM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

M&T Bank's RYTM Position: Q3 2026 in Review

M&T Bank increased its Rhythm Pharmaceuticals (RYTM) stake by 46% in Q3 2026, buying an estimated $106K and bringing the position to 3,173 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

M&T Bank first reported a position in RYTM in Q4 2025 and has held it in 3 quarters since. 148 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • M&T Bank held 3,173 shares of Rhythm Pharmaceuticals worth $302K as of Q3 2026.
  • M&T Bank bought 995 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $106K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1448 holding.
  • M&T Bank first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 148 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.